KFDA to simplify licensing conditions of OTCs, quasi-drugs

Drug manufacturers and quasi-drug makers using 40 standard substances formulation, including herbs and ibuprofen, will be able to market their products with notification only, the Korea Food and Drug Administration on July 21.

The 40 standard substances refer to those whose safety and efficacy is already established and thus the finished products containing them could be released into the ma...